Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - ranitidine hydrochloride - oral tablet - 150mg

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - ranitidine hydrochloride - oral tablet - 300mg

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

bryant ranch prepack - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine 300 mg

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

golden state medical supply, inc. - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine is indicated in: - short-term treatment of active duodenal ulcer. most patients heal within 4 weeks. studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. - maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. no placebo-controlled comparative studies have been carried out for periods of longer than 1 year. - the treatment of pathological hypersecretory conditions (e.g., zollinger-ellison syndrome and systemic mastocytosis). - short-term treatment of active, benign gastric ulcer. most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated. studies available to date have not assessed the safety of ranitidine in uncomplicated, benign gastric ulcer for periods of more than 6 weeks. - maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers. placebo-controlled studies have been carried out for 1 year. -

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

ani pharmaceuticals, inc. - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine is indicated in: concomitant antacids should be given as needed for pain relief to patients with active duodenal ulcer; active, benign gastric ulcer; hypersecretory states; gerd; and erosive esophagitis. ranitidine is contraindicated in patients known to have hypersensitivity to the drug or any of the ingredients (see precautions ).

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

avkare, inc - ranitidine hydrochloride (unii: bk76465ihm) (ranitidine - unii:884kt10yb7) - ranitidine is indicated in: - short-term treatment of active duodenal ulcer. most patients heal within 4 weeks. studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks. - maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. no placebo-controlled comparative studies have been carried out for periods of longer than 1 year. - the treatment of pathological hypersecretory conditions (e.g., zollinger-ellison syndrome and systemic mastocytosis). - short-term treatment of active, benign gastric ulcer. most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated. studies available to date have not assessed the safety of ranitidine in uncomplicated, benign gastric ulcer for periods of more than 6 weeks. - maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers. placebo-controlled studies have been carried out for 1 year. -

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

viatris limited - ranitidine hydrochloride 167.5mg equivalent to ranitidine 150 mg - film coated tablet - 150 mg - active: ranitidine hydrochloride 167.5mg equivalent to ranitidine 150 mg excipient: castor oil colloidal silicon dioxide croscarmellose sodium hypromellose e-15 iron oxide yellow isopropyl alcohol magnesium stearate microcrystalline cellulose purified talc   purified water titanium dioxide - long lasting relief from acid indigestion, heartburn and symptoms resulting from excess stomach acid.

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

viatris limited - ranitidine hydrochloride 335 equivalent to ranitidine 300 mg - film coated tablet - 300 mg - active: ranitidine hydrochloride 335 equivalent to ranitidine 300 mg excipient: castor oil colloidal silicon dioxide croscarmellose sodium hypromellose e-15 iron oxide yellow isopropyl alcohol magnesium stearate microcrystalline cellulose purified talc   purified water titanium dioxide - long lasting relief from acid indigestion, heartburn and symptoms resulting from excess stomach acid.

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

viatris limited - ranitidine hydrochloride 167.5mg equivalent to ranitidine 150 mg - film coated tablet - 150 mg - active: ranitidine hydrochloride 167.5mg equivalent to ranitidine 150 mg excipient: castor oil colloidal silicon dioxide croscarmellose sodium hypromellose e-15 iron oxide yellow isopropyl alcohol magnesium stearate microcrystalline cellulose purified talc purified water titanium dioxide - symptomatic relief of heartburn, dyspepsia and hyperacidity in adults and children over 12 years.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - ranitidine hydrochloride -